BSA as an exogenous protein which enters the human body with drug products, it may cause immune response or affect the effect of the drug. In the third part of the 2020 version of the Chinese Pharmacopoeia, the detection requirements of BSA in some human vaccines are specified: for the original solution verification, it should not be higher than 50ng/mL, the finished product should not be higher than 50ng/dose. The BSA quantitative detection kit independently developed by BioDomi GmbH can quantitatively detect the residue of BSA in various biological products through double antibody sandwich enzyme-linked immunoadsorption.
contact now【Product Name】
BSA ELISA Kit
【Product No.】
S0111B-96
【Tests/kit】
96 Reactions/kit
【Storage】
Store in dark at 2-8℃
Note ：the opened but not used kit shall still be stored in dark condition at 2-8℃.
【Period of validity】
One year
【Packaging】
| Microtiter Plate | 96T(8 x 12 strips) | 2-8℃ |
| Standard(5μg/mL) | 300μL×1 tube | 2-8℃ |
| HRP-Conjugate Antibody | 40μL×1vial | 2-8℃ |
| Buffer (20×) | 30mL×1vial | 2-8℃ |
| Developing solution A | 8mL×1vial | 2-8℃(keep in dark) |
| Developing solution B | 8mL×1vial | 2-8℃(keep in dark) |
| Stop Solution | 15mL×1vial | 2-8℃ |